Symposium: Personalized Patient Care in Cancer Therapy
22-26 February, 2016
Hong Kong, Malaysia, Singapore
A mini-symposium is dedicated for clinical oncology and medical genetics practitioners to meet and discuss about the current practice in molecular testing and its applications in the field of cancer therapy and prevention. Experts from the USA/Singapore will share their perspectives in local practice, discuss the myths and facts about genetic testing, and review medical cases from real clinical settings.
Dr. Mei Peng, Laboratory Director, Angsana Molecular & Diagnostics Laboratory Pte Ltd
Topic: Advantages and limitations of single-gene tests and multi-gene panels in mutation testing of solid tumors.
Dr. Stephen Lincoln, Head of Scientific Affairs, Invitae
Topic: Validity and utility of panel tests for hereditary cancer genes.
SAB Chair at Angsana (HK) Laboratory
27 January, 2016
Prof. Cynthia Morton, Department of Obstetrics, Gynaecology and Reproductive Biology from Harvard Medical School paid a visit to the newly CAP accredited Angsana Hong Kong laboratory. As the chair of Angsana Scientific Advisory Board, Prof. Morton spent one day with the Angsana Hong Kong staff and Dr. Richard Choy, CSO of Angsana to review the key R&D projects in progress.
Public Talk: Is it allergy?
8, 14 & 21 January, 2016 (12:00PM – 2:00PM)
Hong Kong Science and Technology Park, Shatin, Hong Kong
Prof. T.F. Leung, Chairman of Paediatrics, Chinese University of Hong Kong
Topic: Is it allergy?
Dr. Tony Lau, Consultant in Paediatrics, Union Hospital, Hong Kong
Topic: Chronic cough and allergy.
Dr. Agnes Leung, Department of Paediatrics, Chinese University of Hong Kong
Topic: Is it allergy?
Symposium: NIPT and Genetics for every OBGYN
16 January, 2016
Goodwood Park Hotel (Level 2), Singapore
Dr. Carlos Bacino, Profession of Molecular and Human Genetics Department, Baylor College of Medicine
Topic: How to counsel patients with pathogenic CNV and CNV of unknown significance identified by Chromosomal Microarray Analysis (CMA).
Dr. Richard Choy, CSO from Angsana Molecular & Diagnostics Laboratory (HK) Ltd
Topic: Genomic diagnosis of IUGR and NIPT positive cases.
The symposium was co-organized by Obstetrical and Gynaecological Society of Singapore, co-chaired by Dr. Ann Tan, Women & Fetal Center and Dr. Tan Lay Kok, Senior Consultant Obstetrician and Gynaecologist, Singapore General Hospital.
11th Asia Pacific Congress in Maternal Fetal Medicine
27-29 November, 2015
Sheraton Grande Taipei Hotel, Taipei, Taiwan
Session: Advances in Prenatal Genetic & Genomics Diagnosis
28 November, 2015 (2:15PM – 4:30PM)
Speaker: Dr. Richard Choy, Chief Scientific Officer, Angsana Molecular & Diagnostics Laboratory
Topic: Implementation of next-generation sequencing for prenatal diagnosis of copy number variants.
28 November, 2015 (1:15PM – 1:45PM)
Speaker: Dr. Tze Kin Lau, Specialist in Obstetrics & Gynecology, Union Hospital, Hong Kong
Topic: Experience sharing on cfDNA testing in fetal medicine.
Public Talk: Non-Invasive Prenatal Screening (NIPS): Is it right for me?
12 August, 2015
Lecture Room, 2/F Podium, Main Building, Union Hospital, New Territories, Hong Kong
Speaker: Ms. Katelyn Hashimoto, American Board-certified Genetic Counselor, Natera Inc.
Topic: How to properly choose a NIPS?
Speaker: Dr. Tze Kin Lau, Specialist in Obstetrics & Gynaecology, Union Hospital
Topic: How to plan for a healthy baby?
The First Angsana Molecular & Diagnostics Laboratory SAB Meeting
9 May, 2015
The first Angsana Molecular & Diagnostics Laboratory Scientific Advisory Board (SAB) meeting was held in Angsana Hong Kong site, hosted by Dr. Richard Choy, Managing Director of Angsana Molecular & Diagnostics Laboratory (HK) Ltd. The meeting focused on strategy review of Angsana clinical service roadmap, key R&D projects, and future investment directions. Prof. Carlos Bacino and Prof. Sau Wai Cheung from Baylor College of Medicine, Prof. Poh San Lai from National University of Singapore, and Prof. Ka Fai To from Chinese University of Hong Kong joined the meeting in person, while Prof. Cynthia Morton from Harvard Medical School dialled-in remotely.